DrugsControl Media Services

News Detail

Favipiravir: PMS study finds no concerns with the usage (18-09-2021)

Mumbai, 16 Sept 2021: Glenmark Pharmaceuticals, a global integrated pharmaceutical company, on Wednesday announced that the Post-Marketing Surveillance (PMS) study on Favipiravir in India has been completed successfully. The PMS study took place in July last year to evaluate the ......
View Details

Source : Financial Express

Related News